These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

473 related articles for article (PubMed ID: 33240723)

  • 1. Cardiac Adverse Events With Remdesivir in COVID-19 Infection.
    Gupta AK; Parker BM; Priyadarshi V; Parker J
    Cureus; 2020 Oct; 12(10):e11132. PubMed ID: 33240723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Remdesivir therapy causing bradycardia in COVID-19 patients: Two case reports.
    Abdelmajid A; Osman W; Musa H; Elhiday H; Munir W; Al Maslamani MA; Elmekaty EZ
    IDCases; 2021; 26():e01254. PubMed ID: 34401329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The journey of remdesivir: from Ebola to COVID-19.
    Pardo J; Shukla AM; Chamarthi G; Gupte A
    Drugs Context; 2020; 9():. PubMed ID: 32547625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case report on the association between QTc prolongation and remdesivir therapy in a critically ill patient.
    Harbi SA; AlFaifi M; Al-Dorzi HM; Aljuhani O; Alenazi AA; Alalawi M; Sulaiman KA
    IDCases; 2022; 29():e01572. PubMed ID: 35855472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bradycardia Related to Remdesivir During COVID-19: Persistent or Permanent?
    Maheshwari M; Athiraman H
    Cureus; 2021 Nov; 13(11):e19919. PubMed ID: 34956798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case report of QTc prolongation: Drug induced or myocarditis in Severe Acute Respiratory Syndrome Coronavirus 2.
    Gholipour M; Samidoost P; Moayerifar M; Ghasemzadeh G
    SAGE Open Med Case Rep; 2024; 12():2050313X241233432. PubMed ID: 38384983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Remdesivir-Induced Marked Sinus Bradycardia in COVID-19.
    Ahmed T; Lodhi SH; Ahmed T
    Cureus; 2022 Jul; 14(7):e27249. PubMed ID: 36035063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sinus Bradycardia Associated with Remdesivir Treatment in COVID-19: A Case Report and Literature Review.
    Barkas F; Styla CP; Bechlioulis A; Milionis H; Liberopoulos E
    J Cardiovasc Dev Dis; 2021 Feb; 8(2):. PubMed ID: 33673216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Remdesivir-Associated Significant Bradycardia: A Report of Three Cases.
    Shirvani M; Sayad B; Shojaei L; Amini A; Shahbazi F
    J Tehran Heart Cent; 2021 Apr; 16(2):79-83. PubMed ID: 35082876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Remdesivir potently inhibits SARS-CoV-2 in human lung cells and chimeric SARS-CoV expressing the SARS-CoV-2 RNA polymerase in mice.
    Pruijssers AJ; George AS; Schäfer A; Leist SR; Gralinksi LE; Dinnon KH; Yount BL; Agostini ML; Stevens LJ; Chappell JD; Lu X; Hughes TM; Gully K; Martinez DR; Brown AJ; Graham RL; Perry JK; Du Pont V; Pitts J; Ma B; Babusis D; Murakami E; Feng JY; Bilello JP; Porter DP; Cihlar T; Baric RS; Denison MR; Sheahan TP
    bioRxiv; 2020 Apr; ():. PubMed ID: 32511392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Remdesivir-Induced Extreme Sinus Bradycardia in COVID-19.
    Wasef N; Hamilton S; Fatima T; Osgood E
    Cureus; 2022 Jul; 14(7):e27307. PubMed ID: 35910702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Marked Sinus Bradycardia Associated With Remdesivir in COVID-19: A Case and Literature Review.
    Gubitosa JC; Kakar P; Gerula C; Nossa H; Finkel D; Wong K; Khatri M; Ali H
    JACC Case Rep; 2020 Nov; 2(14):2260-2264. PubMed ID: 33163977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Remdesivir-Induced Bradycardia.
    Kanagala SG; Dholiya H; Jhajj P; Patel MA; Gupta V; Gupta S; Wu SI; Jain R
    South Med J; 2023 Mar; 116(3):317-320. PubMed ID: 36863055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Remdesivir associated sinus bradycardia in patients with COVID-19: A prospective longitudinal study.
    Hajimoradi M; Sharif Kashani B; Dastan F; Aghdasi S; Abedini A; Naghashzadeh F; Mohamadifar A; Keshmiri MS; Noorali S; Lookzadeh S; Alizadeh N; Siri MA; Tavasolpanahi M; Abdolmohammadi Y; Shafaghi M; Rouhani ZS; Shafaghi S
    Front Pharmacol; 2022; 13():1107198. PubMed ID: 36733376
    [No Abstract]   [Full Text] [Related]  

  • 15. Remdesivir-Associated Sinus Arrest in COVID-19: A Potential Indication for Close Cardiac Monitoring.
    Gregory GE; Gregory HM; Liaqat H; Ghaly MM; Johnson-Pich KD
    Cureus; 2022 Feb; 14(2):e22328. PubMed ID: 35317046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe Bradycardia Leading to Hemodynamic Instability Associated with Remdesivir Use in a Patient with COVID-19 Pneumonia.
    Donepudi B; Agarwal S; Thakur L
    Case Rep Crit Care; 2022; 2022():8807957. PubMed ID: 36267193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Multicenter Retrospective Analysis on the Etiology of Bradycardia in COVID-19 Patients.
    Umeh C; Giberson C; Kumar S; Aseri M; Barve P
    Cureus; 2022 Jan; 14(1):e21294. PubMed ID: 35186556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Remdesivir induced bradycardia and QT prolongation: A rare side effect of a ubiquitous drug of the COVID -19 era.
    Singla K; Kumar S; Behl A; Puri GD
    J Anaesthesiol Clin Pharmacol; 2022 Jul; 38(Suppl 1):S148-S149. PubMed ID: 36060176
    [No Abstract]   [Full Text] [Related]  

  • 19. Remdesivir-induced symptomatic bradycardia in the treatment of COVID-19 disease.
    Jacinto JP; Patel M; Goh J; Yamamura K
    HeartRhythm Case Rep; 2021 Aug; 7(8):514-517. PubMed ID: 34026493
    [No Abstract]   [Full Text] [Related]  

  • 20. Correction: Template-dependent inhibition of coronavirus RNA-dependent RNA polymerase by remdesivir reveals a second mechanism of action.
    Tchesnokov EP; Gordon CJ; Woolner E; Kocincova D; Perry JK; Feng JY; Porter DP; Götte M
    J Biol Chem; 2021 Aug; 297(2):101048. PubMed ID: 34371377
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 24.